Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Lincoln Pharmaceuticals Limited receives a Patent for Diclofenac Rectal Spray

Posted On: 2019-10-22 15:03:10


Ahmedabad based leading healthcare company, Lincoln Pharmaceuticals Limited is awarded a patent for its liquid Diclofenac Metered-Dose Rectal Spray (Diclofenac Rectal Spray). The patent has been awarded by the Government of India for "A Novel Liquid Rectal Spray Dosage Form Containing Diclofenac and Its Pharmaceutically Active Salts", Patent number - IN320894. This Patent is valid for 20 years. The company has necessary approvals from Drug Controller General of India (DCGI) and planning to launch it in the Indian market by January 2020. The E:ompany is also planning to apply for a Global Patent for this novel solution.

Lincoln Pharma's Liquid rectal spray dosage offers faster and better absorption of die drug res ulting in quick relief and speedy recovery to patients compared to the existing therapeutic options. Clinical Trials conducted suggest that Diclofenac Rectal Spray is highly effective in patients suffering from pre and postoperative pain, gynaecological surgery and musculoskeletal disorders such as muscular pain, pain associated with arthritis, acute pain in renal colic and mild body ache.

Speaking on this development, Mr. Maheni:Jra Patel, Managing Director, Lincoln Pharmaceuticals Limited, said, Globally, No liquid formulation of iclofenac for rectal administration is available. Lincoln Pharma will be the first company to introduce this novel solution aimed at better patient compliance, rapid drug release and greater bioavailability. We have developed this formulation with Diclofenac Sodium BP 25% WN, each squirt delivers Diclofenac Sodium 50 mg, Non-steroidal Anti-inflammatory Agent (NSAIDs). Due to this innovation, now patients can get far better results bY. using Diclofenac Rectal Spray as compared to the existing Diclofenac Suppository available in the market.

Diclofenac Rectal Suppository market is Rs. 20 crore in India and growing at 16% per annum. The company see huge export potential for this product and will start product registration in markets including African continents, Latin America and Southeast Asian markets and gradually expand to other markets.

Shares of LINCOLN PHARMACEUTICALS LTD. was last trading in BSE at Rs.153.55 as compared to the previous close of Rs. 151.45. The total number of shares traded during the day was 3995 in over 166 trades.

The stock hit an intraday high of Rs. 156.65 and intraday low of 152. The net turnover during the day was Rs. 617042.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Jio Platforms receives over Rs. 1.5 lakh crore investment in 3 months

World Youth Skills Day: TCS iON Launches Youth Employability and Entrepreneurship Programme

ICICI Securities Primary Dealership Ltd Q1FY21 net profit surges to Rs. 345.08 crore

Federal Bank Ltd Q1FY21 consolidated PAT higher at Rs. 409.50 crore

Google to invest Rs. 33,737 crore in Jio Platforms Ltd

Indian Metals & Ferro Alloys Ltd postpones board meeting to July 27, 2020

Trigyn awarded - National Cooperative Purchasing Alliance (NCPA) - IT Services Contract

IFGL Refractories Ltd board to consider Q4FY20, FY2020 results, final dividend on July 18, 2020

Bandhan Bank Ltd reports Q1FY21 net profit of Rs. 549.81 crore

TCS Now Second Largest Among UK Software and IT Services Companies

Zydus Cadila receives final approval from USFDA for Betamethasone Dipropionate Ointment

Tata Consumer Products Ltd board to approve Q1FY21 results on Aug 4, 2020

Maruti Suzuki to proactively recall 134,885 units of WagonR and Baleno

NELCO Ltd board to approve quarterly results on July 31, 2020

Sonata Software Ltd board to announce 1st quarter results on Aug 10, 2020

Steel Strips Wheels Ltd bags news orders for mobile home market from USA

Havells India Ltd board to consider Q1FY21 results on July 27, 2020

Zydus starts the Human Dosing for Adaptive Phase I & II clinical trials

Chinese firm announces open offer to acquire shares of Thirdwave Financial Intermediaries Limited

Majesco Enables United Educators Digital Transformation Journey

Aarti Surfactants Ltd FY20 PAT at Rs. 2.09 crore

ICRA Limited Board approves audited financial results for Q4, FY2020

Oriental Hotels Ltd board to approve first quarter results on July 28, 2020

Indiamart Intermesh Ltd board to announce quarterly results on July 21, 2020

Bharti Infratel Ltd board to consider 1st quarter results on July 27, 2020

Monnet Ispat & Energy Ltd board to approve Q1FY21 results on July 21, 2020

ICRA Ltd Board approves Dividend of Rs. 27 for FY20

Vanguard and Infosys announce strategic partnership

India Ratings Downgrades HEG to 'IND AA-'/Stable

Prestige Estates subsidiary acquires equity stake in DB (BKC) Realtors Private Limited

Gujarat Hotels Ltd posts Rs. 0.87 crore PAT in Q1FY21

Oberoi Realty Ltd Q1FY21 consolidated PAT slides to Rs. 28.07 crore

YES Bank approves allocation of 3,415,384,614 Equity Shares to anchor investors

National Peroxide Ltd Board approves dividend of Rs. 12.50

Oberoi Realty Ltd board approves fund raising proposals

Suzlon Energy Limited allots 51,19,92,560 shares

CreditAccess Grameen Limited board to consider terms of NCD issue on July 17, 2020

IDFC First Bank Ltd board to announce Q1FY21 results on July 28, 2020

Oberoi Realty Ltd Q4FY20 consolidated PAT climbs to Rs. 250.96 crore

National Peroxide Ltd Q4FY20 net profit at Rs. 3.03 crore

AAI, BEL sign MoU for co-operation in Civil Aviation industry

Godrej Properties Ltd board to announce Q1FY21 results on Aug 5, 2020

Hero MotoCorp announced as the Title Partner of Hero Open

Opto Circuits India Ltd sinks to FY2020 loss of Rs. 1367.86 crore

Emami group completes stake sale in Emami Cement

ICICI Securities Ltd board to approve 1st quarter results on July 22, 2020

Chambal Fertilisers & Chemicals Ltd board to announce Q1FY21 results on July 29, 2020

Salasar Techno Engineering Ltd updates on tower supply agreement

Dhanlaxmi Bank Limited to exercise call option on bonds

Indo Amines Ltd board to consider Q4FY20 results on July 20, 2020







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019